摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(5-硝基-2-呋喃基)丙烯醛 | 1874-22-2

中文名称
3-(5-硝基-2-呋喃基)丙烯醛
中文别名
5-硝基呋喃-2-丙烯醛
英文名称
5-nitrofurylacrolein
英文别名
5-nitro-2-furanacrolein;3-(5-Nitrofuran-2-yl)prop-2-enal
3-(5-硝基-2-呋喃基)丙烯醛化学式
CAS
1874-22-2
化学式
C7H5NO4
mdl
——
分子量
167.121
InChiKey
DXWCZMGIIFEEPU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    117°C
  • 沸点:
    295.67°C (rough estimate)
  • 密度:
    1.5216 (rough estimate)
  • 稳定性/保质期:
    如果按照规格使用和储存,则不会分解,没有已知的危险反应,应避免接触氧化物。

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    76
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R22,R20/21,R36/37/38
  • 海关编码:
    2932190090
  • 危险性防范说明:
    P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P362,P403+P233,P501,P201,P202,P281,P308+P313,P405
  • 危险性描述:
    H315,H319,H335,H341,H361
  • 储存条件:
    保持贮藏器密封,并将其存放在阴凉、干燥处。确保工作区间有良好的通风或排气装置。

SDS

SDS:f492d73eb8c69fc44ef2f406e6b973d7
查看
Name: 5-Nitro-2-furanacrolein tech 92% Material Safety Data Sheet
Synonym: 3-[(5-Nitro)-2-furanyl]-2-propenal; 5-Nitrofuran-2-acrylaldehyde; 2-Furanacrolein, 5-nitro-; 2-Propenal, 3-(5-nitro-2-furanyl)
CAS: 1874-22-2
Section 1 - Chemical Product MSDS Name:5-Nitro-2-furanacrolein tech 92% Material Safety Data Sheet
Synonym:3-[(5-Nitro)-2-furanyl]-2-propenal; 5-Nitrofuran-2-acrylaldehyde; 2-Furanacrolein, 5-nitro-; 2-Propenal, 3-(5-nitro-2-furanyl)

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
1874-22-2 5-Nitro-2-furanacrolein, tech. 92 217-499-8
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. Use with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1874-22-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: orange-brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 109.00 - 114.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C7H5NO4
Molecular Weight: 167.12

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1874-22-2: LT8530780 LD50/LC50:
Not available.
Carcinogenicity:
5-Nitro-2-furanacrolein, tech. - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1874-22-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1874-22-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1874-22-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A


制备方法与用途

制备方法: β-(5-硝基-2-呋喃基)丙烯醛主要用于合成硝呋肼(Nifurzide)、Furaginum、硝呋马佐(Nifurmade)和硝呋立宗(Nifurizone)。

用途简介: 暂无内容

用途: β-(5-硝基-2-呋喃基)丙烯醛主要用于合成硝呋肼(Nifurzide)、Furaginum、硝呋马佐(Nifurmade)和硝呋立宗(Nifurizone)。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Organocatalytic enantioselective synthesis of 2,3-dihydropyridazines
    作者:Maitane Fernández、Jose L. Vicario、Efraím Reyes、Luisa Carrillo、Dolores Badía
    DOI:10.1039/c2cc17370k
    日期:——
    We have developed an efficient procedure for the easy and straightforward preparation of functionalized dihydropyridazines as highly enantiopure materials by reaction of pyruvaldehyde 2-tosyl hydrazone with a variety of α,β-unsaturated aldehydes using a chiral secondary amine as catalyst. The overall process consists of a cascade reaction involving an initial aza-Michael reaction, in which the stereocentre is installed, followed by an intramolecular aldol reaction/dehydration step.
    我们开发了一种高效的方法,通过使用手性二级胺作为催化剂,将丙酮醛2-托磺酰肼与多种α,β-不饱和醛反应,简单而直接地制备功能化的二氢吡嗪,得到高度对映体纯的材料。整个过程包括一个级联反应,涉及初始的氮杂迈克尔反应,在这一过程中形成了立体中心,然后是一个分子内的醛醇反应/脱水步骤。
  • FURYL AND THIENYL TRIAZOLE DERIVATIVES AND THERAPEUTIC USES THEREOF
    申请人:DENTISTRY OF NEW JERSEY UNIVERSITY OF MEDICINE AND
    公开号:US20140243381A1
    公开(公告)日:2014-08-28
    Nitric oxide biosynthesis-inhibiting anti-inflammatory and anti-microbial compounds of Formula (3) and Formula (4) wherein R1 and R2 are independently selected from optionally substituted thienyl, optionally substituted furyl, optionally substituted —CH═CH-thienyl and optionally substituted provided that R2 is substituted with as nitro group Treatment methods utilizing the compounds, and methods of synthesis of the compounds are also disclosed.
    氮氧化物生物合成抑制抗炎和抗微生物化合物的公式(3)和公式(4),其中R1和R2分别选自可选择取代噻吩基、可选择取代呋喃基、可选择取代-CH═CH-噻吩基和可选择取代,前提是R2被取代为硝基。还公开了利用这些化合物的治疗方法,以及合成这些化合物的方法。
  • Derivatives of 1,2,4-triazole imines acting as dual iNOS and tumor cell growth inhibitors
    作者:Christophe Guillon、Anna M. Vetrano、Jaya Saxena、Angela Hunter、Geraldine Verderone、Thomas M. Finetti、Jeffrey Wisnoski、Peter W. DeMatteo、Robert D. Rapp、Ned D. Heindel、Laurie B. Joseph、Diane E. Heck、Jeffrey D. Laskin
    DOI:10.1016/j.bioorg.2020.104128
    日期:2020.10
    4-(R2-imino)-3-mercapto-5-(R1)-4H-1,2,4-triazoles derivatives were synthesized, characterized and evaluated for their ability to inhibit nitric oxide (NO) production in PAM212 mouse keratinocytes, which led to the discovery and the subsequent evaluation of their growth inhibitory cytotoxic potency toward that same mouse cell line together with a number of human cells lines (PC3, HT-29 and HeLa). Some limited
    合成了一组 4-(R 2 -imino)-3-mercapto-5-(R 1 )-4 H -1,2,4-triazoles 衍生物,表征并评估了它们抑制一氧化氮 (NO) 的能力PAM212 小鼠角质形成细胞中的产生,这导致发现并随后评估了它们对同一小鼠细胞系以及许多人类细胞系(PC3、HT-29 和 HeLa)的生长抑制细胞毒效力。可以为 NO 产生抑制效力和生长抑制细胞毒性建立一些有限的 SAR。值得注意的是,设计为呋喃妥因模拟物的化合物是最有效的抗肿瘤剂。
  • Synthesis and properties of macroheterocyclic azomethines based on 4-aminobenzo-15-crown-5
    作者:N. Yu. Sadovskaya、V. N. Glushko、V. M. Retivov、S. K. Belus’、V. V. Grokhovskii
    DOI:10.1134/s1070363215120191
    日期:2015.12
    number of new stable azomethine crown ether derivatives have been synthesized by condensation of 4-aminobenzo-15-crown-5 with aromatic aldehydes. Complexation of the products with transition metal cations (Cu2+, Zn2+, Fe3+, Co3+, Ni3+) has been studied by spectrophotometry.
    通过将4-氨基苯并-15-冠-5与芳族醛缩合,合成了许多新的稳定的甲亚胺冠醚衍生物。通过分光光度法研究了产物与过渡金属阳离子(Cu 2 +,Zn 2 +,Fe 3+,Co 3+,Ni 3+)的络合。
  • Synthesis and antimicrobial activity of some nitrofuran-containing azomethines
    作者:P. A. Pavlov、N. Yu. Basova、P. P. Pavlov
    DOI:10.1007/bf02524409
    日期:2000.6
    A strategy used fbr the synthesis of well-known nitrofuran derivatives possessing antimicrobial properties consists in the condensation of 5-nitrofurfurol or 5-nitrofurylacrolein with compounds containing primary amino groups. By using 5-nitro-2-furahydrazimide (NFH), incorporating its own C=N fragment, as the nitrofuran-containing component, we may principally change the situation and employ most
    用于合成具有抗微生物特性的众所周知的硝基呋喃衍生物的策略包括将 5-硝基呋喃或 5-硝基呋喃丙烯醛与含有伯氨基的化合物缩合。通过使用 5-硝基-2-呋喃肼 (NFH),结合其自身的 C=N 片段,作为含硝基呋喃的成分,我们可以主要改变这种情况,并在合成中使用最多样化的醛(包括硝基呋喃基团的醛)含硝基呋喃的偶氮甲碱。在这项研究中,我们仅使用四种含硝基呋喃的醛作为含羰基组分合成了一系列新的偶氮甲碱。然而,之前有报道称这些醛类可以产生高效的抗菌制剂 [1, 2]。
查看更多

同类化合物

除草醚 醋糠硫胺 醋呋三嗪 酪氨酰-甘氨酰-色氨酰-蛋氨酰-门冬氨酰-苯基丙氨酰-甘氨酸 糠酸(呋喃甲酸) 糠酸異戊酯 糠酸烯丙酯 碘化溴刚 硫代糠酸甲酯 硝基呋喃杂质 硝呋隆 硝呋醛肟标准品 硝呋美隆 硝呋维啶 硝呋立宗 硝呋甲醚 硝呋烯腙盐酸盐 硝呋烯腙 硝呋替莫 硝呋拉定 硝呋太尔杂质B 硝呋噻唑 硝呋乙宗 盐酸呋喃它酮 盐酸呋喃他酮 甲基7-[5-乙酰氨基-4-[(2-溴-4,6-二硝基苯基)偶氮]-2-甲氧苯基]-3-羰基-2,4,10-三氧杂-7-氮杂十一烷-11-酸酯 甲基5-溴-3-甲基-2-糠酸酯 甲基5-乙酰氨基-2-糠酸酯 甲基5-{[(氯乙酰基)氨基]甲基}-2-糠酸酯 甲基5-(甲氧基甲基)-2-甲基呋喃-3-羧酸酯 甲基5-(溴甲基)-4-(氯甲基)-2-糠酸酯 甲基5-(乙氧基甲基)-2-甲基-3-糠酸酯 甲基5-({[5-(三氟甲基)-2-吡啶基]硫代}甲基)-2-糠酸 甲基5-(4-甲酰基苯基)-2-糠酸酯 甲基5-(3-甲酰基苯基)-2-糠酸酯 甲基4-甲基-3-糠酸酯 甲基4-溴-5-甲基-2-糠酸酯 甲基4-乙酰基-5-甲基-2-糠酸酯 甲基4,6-二氯-3-(二乙基氨基)呋喃并[3,4-c]吡啶-1-羧酸酯 甲基3-羟基呋喃并[3,2-b]吡啶-2-羧酸酯 甲基3-甲酰基-2-糠酸酯 甲基3-氨基呋喃并[2,3-b]吡啶-2-羧酸酯 甲基3-氨基-5-(2-甲基-2-丙基)-2-糠酸酯 甲基3-乙基-4-苯基-2-糠酸酯 甲基3-(叔丁氧基羰基)呋喃-2-羧酸甲酯 甲基2-甲氧基-5-苯基-3-糠酸酯 甲基2-乙基-3-糠酸酯 甲基(2Z)-2-呋喃-2-基-3-(5-硝基呋喃-2-基)丙-2-烯酸酯 甲基(2E)-3-[5-(氯甲酰基)-2-呋喃基]丙烯酸酯 环己基呋喃-2-羧酸酯